Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 12 USDMF, 2 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers

17 API Suppliers
12 USDMF
2 CEP/COS
1 EU WC
3 NDC API
5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers, 29 FDA Orange Book, 24 Europe, 18 South Africa, 6 Listed Dossiers

77 FDF Dossiers
29 FDA Orange Book
24 Europe
18 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML, CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

drugProductComposition
FOR SOLUTION;ORAL - 10MG/ML
CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 13 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 7 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 15 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives, 36 Controlled & Modified Release, 26 Thickeners and Stabilizers, 26 Fillers, Diluents & Binders, 25 Disintegrants & Superdisintegrants, 17 Direct Compression, 14 Granulation, 13 Solubilizers, 13 Film Formers & Plasticizers, 12 Taste Masking, 11 Topical, 9 Empty Capsules, 8 Lubricants & Glidants, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 3 Parenteral, 2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

8 Finished Drug Prices

globalSalesInformation
8 Finished Drug Prices

MARKET PLACE

1 FDF Dossiers

marketPlace
1 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM , 4 USP , 4 Others

otherSolutions
4 EDQM
4 USP
4 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

185 RELATED EXCIPIENT COMPANIES

310EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₁₀H₁₂N₄O₃

Molecular Weight

236.23 g/mol

InChI Key

BXZVVICBKDXVGW-NKWVEPMBSA-N

1 2D Structure

Didanosine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one

2.1.2 InChI

InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1

2.1.3 InChI Key

BXZVVICBKDXVGW-NKWVEPMBSA-N

2.1.4 Canonical SMILES

C1CC(OC1CO)N2C=NC3=C2NC=NC3=O

2.1.5 Isomeric SMILES

C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O

2.2 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₁₂N₄O₃
Molecular Weight	236.23 g/mol
XLogP3	-1.2
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	2
Exact Mass	236.09094026 g/mol
Monoisotopic Mass	236.09094026 g/mol
Topological Polar Surface Area	88.7 A^2
Heavy Atom Count	17
Formal Charge	0
Complexity	348
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 6
Drug Name	Didanosine
Drug Label	Didanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active Ingredient	Didanosine
Dosage Form	Capsule, delayed rel pellets; Tablet, for suspension; For solution
Route	Oral
Strength	200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market Status	Prescription
Company	Mylan Pharms; Aurobindo; Aurobindo Pharma; Barr

2 of 6
Drug Name	Videx
PubMed Health	Didanosine (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	VIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active Ingredient	Didanosine
Dosage Form	For solution
Route	Oral
Strength	10mg/ml
Market Status	Prescription
Company	Bristol Myers Squibb

3 of 6
Drug Name	Videx ec
PubMed Health	Didanosine (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	VIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active Ingredient	Didanosine
Dosage Form	Capsule, delayed rel pellets
Route	Oral
Strength	200mg; 250mg; 125mg; 400mg
Market Status	Prescription
Company	Bristol Myers Squibb

4 of 6
Drug Name	Didanosine
Drug Label	Didanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active Ingredient	Didanosine
Dosage Form	Capsule, delayed rel pellets; Tablet, for suspension; For solution
Route	Oral
Strength	200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market Status	Prescription
Company	Mylan Pharms; Aurobindo; Aurobindo Pharma; Barr

5 of 6
Drug Name	Videx
PubMed Health	Didanosine (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	VIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active Ingredient	Didanosine
Dosage Form	For solution
Route	Oral
Strength	10mg/ml
Market Status	Prescription
Company	Bristol Myers Squibb

6 of 6
Drug Name	Videx ec
PubMed Health	Didanosine (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	VIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active Ingredient	Didanosine
Dosage Form	Capsule, delayed rel pellets
Route	Oral
Strength	200mg; 250mg; 125mg; 400mg
Market Status	Prescription
Company	Bristol Myers Squibb

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - FOR SOLUTION;ORAL - 10MG/ML

USFDA APPLICATION NUMBER - 20156

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

Controlled & Modified Release

Thickeners and Stabilizers

Fillers, Diluents & Binders

Disintegrants & Superdisintegrants

Direct Compression

Granulation

Solubilizers

Film Formers & Plasticizers

Taste Masking

Topical

Empty Capsules

Lubricants & Glidants

Co-Processed Excipients

Rheology Modifiers

Coloring Agents

Emulsifying Agents

Vegetarian Capsules

API Stability Enhancers

Chewable & Orodispersible Aids

Parenteral

Surfactant & Foaming Agents

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Didanosine manufacturers, exporters & distributors on PharmaCompass

Didanosine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

12 USDMF

2 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers

29 FDA Orange Book

24 Europe

18 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik

1 Rochem International Inc

1 SPI Pharma

2 Seqens

9 DKSH

1 Jai Radhe Sales

8 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

18 BASF

13 Corel Pharma Chem

4 DFE Pharma

3 Doshion Polyscience

2 Finar

7 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

15 Kerry

4 Kima Chemical

6 Lonza Capsugel

6 Microlex e.U

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

12 Roquette

7 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

3 The Dow Chemical Company

2 Valens Pharmachem

3 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives

36 Controlled & Modified Release

26 Thickeners and Stabilizers

26 Fillers, Diluents & Binders

25 Disintegrants & Superdisintegrants

17 Direct Compression

14 Granulation

13 Solubilizers

13 Film Formers & Plasticizers

12 Taste Masking

11 Topical

9 Empty Capsules

8 Lubricants & Glidants

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons